NEA

Anterior, a company that uses AI to expedite health insurance approval for medical procedures, has raised a $20 million Series A round at a $95 million post-money valuation led by NEA, according to two people familiar with the deal. Existing investors Sequoia, which led Anterior’s $3.2 million seed round last September, and Neo, an accelerator that helped the company launch in the summer of 2022, also participated in the Series A financing. The company has built an LLM-powered co-pilot that helps nurses and doctors save hours on gathering medical documentation required by insurance. While Anterior’s initial offering is in prior authorization automation, the company eventually plans to expand into other medical administrative functions. Makhzoimi also backed Xaira, an AI drug discovery startup that launched this year with $1 billion in funding.